223 related articles for article (PubMed ID: 30076714)
41. Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating ∆NP63 by sponging miR-762.
Liu T; Lu Q; Liu J; Xie S; Feng B; Zhu W; Liu M; Liu Y; Zhou X; Sun W; Zhang Y; Chen X; Fang F; Guo H; Yang R
Cell Death Dis; 2020 Jan; 11(1):47. PubMed ID: 31969560
[TBL] [Abstract][Full Text] [Related]
42. LncRNA PVT1 promotes bladder cancer progression by forming a positive feedback loop with STAT5B.
Li Z; Fu H; Liu J; Song W; Zeng M; Wang J
Pathol Res Pract; 2023 Aug; 248():154635. PubMed ID: 37392551
[TBL] [Abstract][Full Text] [Related]
43. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
44. The long noncoding RNA LINC01140/miR-140-5p/FGF9 axis modulates bladder cancer cell aggressiveness and macrophage M2 polarization.
Wu S; Xu R; Zhu X; He H; Zhang J; Zeng Q; Wang Y; Zhao X
Aging (Albany NY); 2020 Nov; 12(24):25845-25864. PubMed ID: 33234721
[TBL] [Abstract][Full Text] [Related]
45. miR-140-3p inhibits bladder cancer cell proliferation and invasion by targeting FOXQ1.
Wang Y; Chen J; Wang X; Wang K
Aging (Albany NY); 2020 Oct; 12(20):20366-20379. PubMed ID: 33098639
[TBL] [Abstract][Full Text] [Related]
46. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
47. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
48. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
[TBL] [Abstract][Full Text] [Related]
49. The long noncoding RNA PVT1 functions as a competing endogenous RNA by sponging miR-186 in gastric cancer.
Huang T; Liu HW; Chen JQ; Wang SH; Hao LQ; Liu M; Wang B
Biomed Pharmacother; 2017 Apr; 88():302-308. PubMed ID: 28122299
[TBL] [Abstract][Full Text] [Related]
50. Circular RNA circUBXN7 represses cell growth and invasion by sponging miR-1247-3p to enhance B4GALT3 expression in bladder cancer.
Liu H; Chen D; Bi J; Han J; Yang M; Dong W; Lin T; Huang J
Aging (Albany NY); 2018 Oct; 10(10):2606-2623. PubMed ID: 30312173
[TBL] [Abstract][Full Text] [Related]
51. Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b.
Zhang S; Zhang G; Liu J
APMIS; 2016 Aug; 124(8):649-58. PubMed ID: 27272214
[TBL] [Abstract][Full Text] [Related]
52. Long noncoding RNA AC114812.8 promotes the progression of bladder cancer through miR-371b-5p/FUT4 axis.
Li W; Li Y; Ma W; Zhou J; Sun Z; Yan X
Biomed Pharmacother; 2020 Jan; 121():109605. PubMed ID: 31706102
[TBL] [Abstract][Full Text] [Related]
53. LncRNA RP11-79H23.3 Functions as a Competing Endogenous RNA to Regulate PTEN Expression through Sponging hsa-miR-107 in the Development of Bladder Cancer.
Chi H; Yang R; Zheng X; Zhang L; Jiang R; Chen J
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149689
[TBL] [Abstract][Full Text] [Related]
54. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
[TBL] [Abstract][Full Text] [Related]
55. LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling.
Chen J; Li Y; Li Z; Cao L
J Biochem Mol Toxicol; 2020 Apr; 34(4):e22452. PubMed ID: 32052927
[TBL] [Abstract][Full Text] [Related]
56. PVT1 (rs13281615) and miR-146a (rs2910164) polymorphisms affect the prognosis of colon cancer by regulating COX2 expression and cell apoptosis.
Zhang W; Xiao J; Lu X; Liu T; Jin X; Xiao Y; He X
J Cell Physiol; 2019 Aug; 234(10):17538-17548. PubMed ID: 30820968
[TBL] [Abstract][Full Text] [Related]
57. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression.
Meng L; Xing Z; Guo Z; Liu Z
Cell Death Dis; 2020 Dec; 11(12):1063. PubMed ID: 33311496
[TBL] [Abstract][Full Text] [Related]
58. Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer.
Chang Z; Cui J; Song Y
Gene; 2018 May; 654():36-42. PubMed ID: 29452232
[TBL] [Abstract][Full Text] [Related]
59. Long Noncoding RNA Plasmacytoma Variant Translocation 1 (PVT1) Promotes Colon Cancer Progression via Endogenous Sponging miR-26b.
Zhang R; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Liu Y
Med Sci Monit; 2018 Dec; 24():8685-8692. PubMed ID: 30504754
[TBL] [Abstract][Full Text] [Related]
60. LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a.
Liu HT; Fang L; Cheng YX; Sun Q
Cancer Med; 2016 Dec; 5(12):3512-3519. PubMed ID: 27794184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
